- Molecular Characterization of Hard Ticks by Cytochrome c Oxidase Subunit 1 Sequences
-
Gou H, Xue H, Yin H, Luo J, Sun X
- KMID: 2441619
- Korean J Parasitol.
- 2018 Dec;56(6):583-588.
- doi: 10.3347/kjp.2018.56.6.583
Although widely studied, the natural diversity of the hard tick is not well known. In this study, we collected 194 sequences from 67 species, covering 7 genera of hard tick.... -
- CITED
-
- Close
- SHARE
-
- Close
- Phylogenetic Analysis of Ruminant Theileria spp. from China Based on 28S Ribosomal RNA Gene
-
Gou H, Guan G, Ma M, Liu A, Liu Z, Xu Z, Ren Q, Li Y, Yang J, Chen Z, Yin H, Luo J
- KMID: 1792141
- Korean J Parasitol.
- 2013 Oct;51(5):511-517.
Species identification using DNA sequences is the basis for DNA taxonomy. In this study, we sequenced the ribosomal large-subunit RNA gene sequences (3,037-3,061 bp) in length of 13 Chinese Theileria... -
- CITED
-
- Close
- SHARE
-
- Close
- Hounsfield Units as an Independent Predictor of Failed Percutaneous Drainage of Spinal Tuberculosis Paraspinal Abscess Under Computed Tomography Guidance
-
Xiang Y, He J, Bai R, Gou H, Luo F, Huang X, Zhang Z
- KMID: 2549862
- Neurospine.
- 2023 Dec;20(4):1389-1398.
- doi: 10.14245/ns.2346820.410
Objective: To investigate the value of Hounsfield units (HUs) as an independent predictor of failed percutaneous drainage of spinal tuberculosis paraspinal abscess under computed tomography (CT) guidance. Methods: A retrospective analysis... -
- CITED
-
- Close
- SHARE
-
- Close
- A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
-
Liu T, Li Q, Lin Z, Liu C, Pu W, Zeng S, Lai J, Cai X, Zhang L, Wang S, Chen M, Cao W, Gou H, Zhu Q
- KMID: 2554349
- Cancer Res Treat.
- 2024 Apr;56(2):602-615.
- doi: 10.4143/crt.2023.726
Purpose Patients with advanced biliary tract cancer (BTC) have a poor survival. We aim to evaluate the efficacy and safety of nab-paclitaxel plus gemcitabine and cisplatin regimen in Chinese advanced... -
- CITED
-
- Close
- SHARE
-
- Close
